Dr. Michael J. Dans, MD

Dr. Dans practices at San Francisco Dermatology Inc in San Francisco, California.

Dr. Dans' NPI, 1235213208, was assigned on October 25, 2006. Dr. Dans graduated from New York University School of Medicine in 2001. Dr. Dans holds California license A89288.

Dr. Dans' primary practice is San Francisco Dermatology Inc, at 490 Post St, San Francisco, CA 94102 in San Francisco County. The practice phone is (415) 781-1932.

Dr. Dans' primary practice is San Francisco Dermatology Inc in San Francisco, California. The medical group on file is Dermatology Medical Group of San Francisco. Dmand AI also links Dr. Dans to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dans practices. Vendor and product names are available with a free account.

Dermatology is Dr. Dans' primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Dans is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Dans' licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, hives, itchy rashes and psoriasis among the conditions Dr. Dans treats.

CMS data shows 5,525 Medicare services from Dr. Dans across 18 procedure codes in 2024, for 658 Medicare patients. Medicare paid $201,283 for them. Every service was in an office.

CMS counts 658 Medicare patients who saw Dr. Dans in 2024. The largest group is 75 to 84, with 305 patients. 75% of them have high cholesterol, and 59% have high blood pressure. 5% are also on Medicaid. Their average risk score is 0.90, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dans' median patient age at 62, with 33% women.

In 2024, Dr. Dans wrote 914 Medicare Part D claims for 351 patients. 94% of them were for generic drugs. CMS names the drug for 747 of them, across 20 drugs with 11 or more claims each, at $79,796 in total drug cost. In 2023, CMS named 615 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Dans for performance year 2024, reported individually. Dr. Dans accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,326 procedures of removal of skin lesions by Dr. Dans, more than 95% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Dans, published from 2004 to 2023. The most frequent topics are Integrins, Cells, Cultured and Signal Transduction. Dr. Dans' most frequent co-authors are Leonard Mark Dzubow, MD and Chad M. Hivnor, MD.

CMS Open Payments shows 27 general payments to Dr. Dans from 10 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 90% of the total. Allergan Inc. paid the most, $279.

Dmand AI lists 3 awards for Dr. Dans, most recently CMS Stage 1 EHR in 2013.

Dr. Dans graduated from New York University School of Medicine in 2001. Dr. Dans is a member of AAD and ASDS.

Dr. Dans is in network with 10 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.